The word “Vyluma,” originates from different languages across the globe and carries the meaning to expand and open to light. Vyluma, a biopharmaceutical company, specializes in creating innovative eye drop treatments for global ophthalmic diseases. Their dedicated team aims to enhance patients' quality of life by preserving their vision through transformative therapeutics. Working alongside eye care clinicians, they strive to revolutionize the current standard of care with with regard to myopia management.